“These findings highlight the potential of self-complementary AAVs to reduce dose requirements, minimize toxicity, and broaden clinical use of inner-ear therapies,” said the head researcher.
|  Read More  JPost.com – The Jerusalem Post – All News from the Middle East, Israel, and the Jewish World